IBN SINA Pharmaceutical Industry PLC 2021 Annual Report with Sustainability Disclosures
Company: IBN SINA Pharmaceutical Industry PLC
Sector: Manufacturing
Country: Bangladesh
Year: 2021
Type: Annual Report with Sustainability Disclosures
Pages: 215
The report covers the year ended 30 June 2021 and records consolidated revenue of Tk. 7,376,042,094, with 19.13% sales growth. It highlights continued pharmaceutical production during COVID-19, the near-completion of API and Natural Medicine projects, and formation of a new Natural Medicine subsidiary. Sustainability disclosures center on four priorities: responsible and ethical operations, support for patients and communities, enabling people, and minimizing environmental impacts. CSR activities included free medical treatment, a health magazine, medicine donations and tree plantation.
Reporting standards, commitments and assurance details are available with a free account.
Data Services
From bulk PDFs to structured indicators and machine-readable documents.